Join the Prostate Cancer group to help and get support from people like you.
Prostate Cancer News
Related terms: Cancer, Prostate, Carcinoma of Prostate
About One in Six Men With Grade Group 1 Prostate Cancer Has Intermediate-, High-Risk Disease
WEDNESDAY, Aug. 6, 2025 – A proportion of men with grade group 1 (GG1) prostate cancer have a higher-risk disease than suggested by biopsy, according to a study published online July 31 in JAMA...
Are Some 'Low-Grade' Prostate Cancers More Deadly Than Thought?
FRIDAY, August 1, 2025 — Men diagnosed with what are known as Grade Group one (GG1) prostate tumors are often told they don’t require treatment, only “watchful waiting,” because GG1 cancers are at low...
Racial Differences Seen in Prostate Cancer Care Quality
WEDNESDAY, July 30, 2025 – Black men with newly diagnosed prostate cancer have lower odds of overtreatment and confirmatory testing when compared with White men, according to a research letter...
Risk for Death From Prostate Cancer Low With Guideline Care for Nonmetastatic Disease
MONDAY, July 14, 2025 – Men with nonmetastatic prostate cancer receiving guideline-concordant care have a much higher risk for death from causes other than prostate cancer, according to a study...
ESPN's Jay Harris Diagnosed With Prostate Cancer
FRIDAY, June 6, 2025 — Longtime ESPN “SportsCenter” anchor Jay Harris has been diagnosed with prostate cancer and is scheduled to have surgery on June 10. Harris, 60, wrote about his experience in an ...
U.S. FDA Approves Third Indication of Nubeqa (darolutamide) for Patients with Advanced Prostate cancer
Berlin, June 3, 2025 – Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved its oral androgen receptor inhibitor (ARi) Nubeqa (darolutamide) in combination with a...
Acupuncture May Alleviate Nocturia in Men Treated for Prostate Cancer
TUESDAY, June 3, 2025 – Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online May 29 in JAMA Oncology. Kevin T. Liou, M.D., from ...
Biden’s Prostate Cancer Likely Grew Undetected for Years, Experts Say
FRIDAY, May 23, 2025 — Former President Joe Biden's prostate cancer diagnosis has drawn attention to screening guidelines for older men. When Biden, 82, was diagnosed last week, his cancer had al...
Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy
TUESDAY, May 20, 2025 – Post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is well tolerated, with patient-reported outcomes (PROs) comparable to those seen after...
Former President Joe Biden Diagnosed With Aggressive Prostate Cancer
MONDAY, May 19, 2025 — Former President Joe Biden has been diagnosed with advanced prostate cancer that has spread to his bones, his office announced Sunday. Doctors found the cancer after Biden r...
MRI-Guided Biopsy Linked to Durability of Active Surveillance in Prostate Cancer
MONDAY, May 19, 2025 – Use of magnetic resonance imaging (MRI)-guided biopsy (MRGB) could increase the durability of active surveillance (AS) in men with prostate cancer, according to a study...
Improvements In Prostate Cancer Tracking Help Men Stay In Active Surveillance
THURSDAY, May 15, 2025 — Men in “watchful waiting” mode for their low-risk prostate cancer are staying healthier longer thanks to advanced imaging and treatments designed to keep their tumor at bay, a...
Since 2010, Fewer Prostatectomies Being Performed for Lowest-Risk Prostate Cancer
TUESDAY, May 13, 2025 – Since 2010, there has been a decrease in the proportion of prostatectomies that are pathologic grade group 1 (pGG1), according to a study published online April 28 in JAMA...
Worried About Prostate Cancer Screening? New Study Shows Better Judgment In Treatment
THURSDAY, May 8, 2025 – Some men would rather skip screening for prostate cancer due to fears that they’ll be rendered impotent or incontinent from cancer surgery. But new research says those fears a...
Ultra-Hypofractionated Radiotherapy Noninferior for Prostate Cancer
THURSDAY, May 8, 2025 – Ultra-hypofractionated (UHF) radiotherapy delivered over two weeks is noninferior to conventionally fractionated (CF) radiotherapy delivered over eight weeks for localized...
Further information
Related condition support groups
Related drug support groups
Lupron, Lupron Depot, estradiol, Premarin, Estrace, Xtandi, docetaxel, Zytiga